FDA Approves Lamzede (velmanase alfa-tycv) for the Treatment of Alpha-Mannosidosis

First and only enzyme replacement therapy for the treatment of non-central nervous system manifestations of alpha-mannosidosis in adult and pediatric patients Ultra-rare progressive disease presents with wide range of symptoms BOSTON, Feb. 16, 2023 /PRNewswire/ — Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced today that the U.S. Food […]

Continue reading »

As Opioids Mixed With Animal Tranquilizers Arrive in Kensington, So Do Alarming Health Challenges

Many people living on the streets in Philadelphia’s Kensington neighborhood — the largest open-air drug market on the East Coast — are in full-blown addiction, openly snorting, smoking, or injecting illicit drugs, hunched over crates or on stoops. Syringes litter sidewalks, and the stench of urine fouls the air. The neighborhood’s afflictions date to the early 1970s, when industry left […]

Continue reading »

NY requiere que doctores receten naloxona a algunos pacientes que toman analgésicos opioides

Sin analgésicos opioides para aliviar el dolor de rodillas y otras articulaciones, Arnold Wilson no podría caminar media cuadra. El ex enfermero de la ciudad de Nueva York, de 63 años, tiene una artritis incapacitante y toma OxyContin dos veces al día, y oxicodona cuando necesita un alivio adicional. En los últimos años, también ha tenido otro remedio a mano: […]

Continue reading »

Misinformation Clouds America’s Most Popular Emergency Contraception

A brand of specialty mozzarella cheeses. A collection of natural-gas storage terminals. And America’s top-selling emergency contraception. At a moment when half of U.S. states stand poised to outlaw or sharply curtail abortion services, the last-ditch pill for women aiming to stave off an unwanted pregnancy rests in the unlikely stewardship of two private equity firms whose investment portfolios range […]

Continue reading »

Changes to Medi-Cal’s Troubled Drug Program Reduce Backlog in California, but Problems Persist

SACRAMENTO, Calif. — The contractor running California’s new Medicaid prescription drug program has addressed shortfalls that earlier this year left thousands of enrollees without critical medications, some languishing on hold for hours as they sought help, state officials told lawmakers Thursday.  But doctors and health care clinics say that some patients are still suffering and that the state and its contractor, […]

Continue reading »

Colchones y remoción de moho: Medi-Cal ofrecerá tratamientos no tradicionales a personas con asma

MADERA, California. – Al crecer en medio de los polvorientos campos agrícolas del Valle Central, Ruby Marentes-Cabrera no puede recordar un momento en el que no fuera difícil respirar. Diagnosticada con asma de pequeña, la estudiante de noveno grado ha llegado a detestar los árboles de pistacho que rodean su casa. El polvo, los pesticidas y otros alérgenos de las […]

Continue reading »

FDA Approves Skytrofa

FDA Approves Skytrofa (lonapegsomatropin-tcgd) for the Once-Weekly Treatment of Pediatric Growth Hormone Deficiency COPENHAGEN, Denmark, Aug. 25, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to potentially create new treatments that make a meaningful difference in patients’ lives, today announced that the U.S. Food and Drug Administration (FDA) has approved […]

Continue reading »

FDA Approves Expanded Botox (onabotulinumtoxinA) Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity

NORTH CHICAGO, Ill., July 29, 2021 /PRNewswire/ — Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion of Botox® to include eight new muscles for the treatment of upper limb spasticity in adults. The new muscles for treatment include additional muscles of the elbow and forearm (brachialis, brachioradialis, […]

Continue reading »

Journalists Track Biden’s First 100 Days

Chief Washington correspondent Julie Rovner discussed Biden’s first 100 days on WAMU/NPR’s “1A” on Wednesday. She also joined Wisconsin Public Radio’s “Central Time” to talk about why hospitals aren’t cooperating with price transparency requirements. Click here to hear Rovner on WAMU/NPR Read Rovner’s “The Great Undoing: Which of Trump’s Policies Will Biden Reverse?” Click here to hear Rovner on Wisconsin […]

Continue reading »
1 2 3 14